CASP3 and cancer: TA had no consistent effect on ERK or AKT phosphorylation, Cyclin D1 or Cyclin B1 levels, or PARP or Caspase 3 cleavage across the MDA-MB-468, BT474, and WM793 human cancer cell lines (Supplementary Figure S1B).